 | Articles: Drug Trials |
Gilead Announces Interim 12-Month Phase III Study Results for Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
Corporate News Releases, 06/17/08
NicOx announces blood pressure analysis from 301 phase 3 study for naproxcinod at EULAR
Corporate News Releases, 06/17/08
New Data Demonstrates Joint Damage is Inhibited With Wyeth's Biologic Enbrel(R) Plus Methotrexate in Patients With Early Active Rheumatoid Arthritis
Corporate News Releases, 06/16/08
Bristol-Myers and Pfizer initiate new Phase III thromboembolism trial
PharmiWeb, 06/16/08
Array BioPharma Presents Additional Positive Phase 1 Results in Two Programs at the 2008 Annual European Congress of Rheumatology
Array BioPharma, 06/16/08
EpiCept Releases New Ceplene AML Data Demonstrating Leukemia Free Survival as Predictor of Improved Overall Survival
Corporate News Releases, 06/16/08
The Power of Hypothesis
BioPharm, 06/13/08
Roche moves investigational diabetes drug, taspoglutide, into phase iii clinical trials
Roche, 06/13/08
Ofatumumab in subcutaneous study in rheumatoid arthritis
Genmab, 06/13/08
Biovest Reports Blinded Results for Phase 3 Study Evaluating Anti-Cancer Vaccine, BiovaxID(R), which Shows 100% Difference in Disease-Free Survival at 36 Months in the Comparative Arms
Corporate News Releases, 06/13/08
|
 Receive daily email updates on Drug Trials
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
 |
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
|
